Literature DB >> 18370518

A comparative survey of antidepressant drug prescribing habits of general practitioners and psychiatrists.

M Lapeyre-Mestre1, K Desboeuf, I Aptel, J J Chale, J L Montastruc.   

Abstract

OBJECTIVE: Clinical experience suggests important differences in prescriptions from general practitioners and specialists. This study investigated these differences and their determinants for antidepressant drug prescribing intentions by general practitioners and psychiatrists in France. STUDY PARTICIPANTS: In May 1995, a mail questionnaire was sent to a representative panel of 300 general practitioners and 100 psychiatrists from the Midi-Pyrenees area (South West France). Two types of questions were asked: the first concerned the type of antidepressants prescribed according to the characteristics of depression ('severe', with insomnia, anxiety, etc.) and the second, the factors influencing prescriptions (personal experience, adverse effects, clinical trials, cost, etc.).
RESULTS: 151 general practitioners (51%) and 63 psychiatrists (63%) answered the questionnaire. The analysis showed large differences between the two groups of physicians. Serotoninergic antidepressants were reported to be the most common first-line drugs of choice in both groups of practitioners. General practitioners claimed to prescribe serotoninergic antidepressants more frequently than psychiatrists (74 vs 59%, p < 0.05). Psychiatrists were reported to prescribe higher dosages of antidepressants than general practitioners in 'severe' depression (109.7 vs 85.6mg daily, p < 0.001). General practitioners were reported to prescribe anxiolytic agents more frequently than psychiatrists (73 vs 54%, p < 0.05), and neuroleptic agents less frequently (1 vs 11%, p < 0.001). The factors reported to influence antidepressant prescription differed in the two groups of physicians. Postuniversity teaching, hospital specialist information and registered indication were considered more important by general practitioners than psychiatrists, who reported to be more influenced by patients' and colleagues' opinions.
CONCLUSION: These results demonstrated that the differences in intention in prescribing between psychiatrists and general practitioners can be explained by a different approach to prescription since psychiatrists place more importance on human and clinical factors (patients' and colleagues' opinions) than general practitioners, who referred more to 'official' data (university, hospital and registered indications).

Entities:  

Year:  1998        PMID: 18370518     DOI: 10.2165/00044011-199816010-00007

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  15 in total

Review 1.  Recognition and management of depression in general practice: consensus statement.

Authors:  E S Paykel; R G Priest
Journal:  BMJ       Date:  1992-11-14

2.  Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.

Authors:  S A Montgomery; S Kasper
Journal:  Int Clin Psychopharmacol       Date:  1995-01       Impact factor: 1.659

3.  Antidepressant prescribing: a comparison between general practitioners and psychiatrists.

Authors:  M P Kerr
Journal:  Br J Gen Pract       Date:  1994-06       Impact factor: 5.386

4.  Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.

Authors:  I M Anderson; B M Tomenson
Journal:  BMJ       Date:  1995-06-03

Review 5.  New or old antidepressants? Benefits of new drugs are exaggerated.

Authors:  D Owens
Journal:  BMJ       Date:  1994-11-12

6.  The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants.

Authors:  I M Anderson; B M Tomenson
Journal:  J Psychopharmacol       Date:  1994-01       Impact factor: 4.153

7.  A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies.

Authors:  F J Mackay; N R Dunn; L V Wilton; G L Pearce; S N Freemantle; R D Mann
Journal:  Pharmacoepidemiol Drug Saf       Date:  1997-07       Impact factor: 2.890

8.  Trends in the prescription of antidepressants by office-based psychiatrists.

Authors:  M Olfson; G L Klerman
Journal:  Am J Psychiatry       Date:  1993-04       Impact factor: 18.112

9.  Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.

Authors:  F Song; N Freemantle; T A Sheldon; A House; P Watson; A Long; J Mason
Journal:  BMJ       Date:  1993-03-13

10.  Choice of antidepressants: questionnaire survey of psychiatrists and general practitioners in two areas of Sweden.

Authors:  G Isacsson; I Redfors; D Wasserman; U Bergman
Journal:  BMJ       Date:  1994-12-10
View more
  2 in total

1.  Knowledge About Recommended Treatment and Management of Major Depressive Disorder, Panic Disorder, and Generalized Anxiety Disorder Among Family Physicians.

Authors:  David Katerndahl; Robert L. Ferrer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

2.  Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications.

Authors:  V Abbing-Karahagopian; C Huerta; P C Souverein; F de Abajo; H G M Leufkens; J Slattery; Y Alvarez; M Miret; M Gil; B Oliva; U Hesse; G Requena; F de Vries; M Rottenkolber; S Schmiedl; R Reynolds; R G Schlienger; M C H de Groot; O H Klungel; T P van Staa; L van Dijk; A C G Egberts; H Gardarsdottir; M L De Bruin
Journal:  Eur J Clin Pharmacol       Date:  2014-05-03       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.